Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
La Revue De Medecine Interne|April 14, 2000
[Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects]J L Cracowski, F Stanke-Labesque, G BessardPathologie-Biologie|July 12, 2005
[Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods]O Berdeaux, O Scruel, T Durand, et al.Therapie|August 21, 2002
[Leukotrienes and 12-HETE: key mediators of angiotensin II-mediated vascular effects.Rol in hypertension]F Stanke-Labesque, G Hardy, J L Cracowski, et al.Presse Medicale (Paris, France : 1983)|April 25, 2000
[Isoprostanes: new markers of oxidative stress in human diseases]J L Cracowski, F Stanke-Labesque, C Souvignet, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Syntheses and preliminary pharmacological evaluation of the two epimers of the 5-F2t-isoprostaneT Durand, J L Cracowski, A Guy, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|May 8, 2001
Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassayJ Bessard, J L Cracowski, F Stanke-Labesque, et al.Fundamental & Clinical Pharmacology|February 19, 2000
Are isoprostanes a clinical marker for antioxidant drug investigation?C Souvignet, J L Cracowski, F Stanke-Labesque, et al.Therapie|June 22, 2000
[In vitro study of of the effects of cysteinyl leukotrienes on human vascular preparations]F Stanke-Labesque, J L Cracowski, P Devillier, et al.Clinical Cardiology|March 9, 1999
Thrombolysis of mobile right atrial thrombi following severe pulmonary embolismJ L Cracowski, F Tremel, J P Baguet, et al.Journal Des Maladies Vasculaires|April 29, 1998
[Deep venous thrombosis and severe burns]J L Cracowski, J L Bosson, C Cracowski, et al.Pageof 9